United States News Todas as matérias

SEALSQ (NASDAQ:LAES), a developer of specialized semiconductors and post-quantum technology, announced preliminary financial results for the first quarter of 2026 on April 8, featuring a triple-digit revenue surge and a substantial expansion of its cash reserves.

Virco (NASDAQ:VIRC), the domestic manufacturer and supplier of furniture and equipment for the education market, reported full-year financial results for the fiscal year ended January 31, 2026, characterized by steady annual earnings and a robust liquidity position.

Unity (NYSE:U), the prominent provider of tools for creating and growing real-time 3D content, and Meta (NASDAQ:META) announced an extended multi-year platform support and enterprise agreement on April 8, 2026.

Atkore (NYSE:ATKR) announced on April 8, 2026, the sale of its High-Density Polyethylene (HDPE) pipe and conduit business to Infra Pipes, a prominent North American manufacturer of polyethylene pipeline solutions.

Adagio Medical Holdings (NASDAQ:ADGM) announced on April 8, 2026, that the U.S. Food and Drug Administration (FDA) granted Investigational Device Exemption (IDE) approval to expand its FULCRUM-VT clinical trial.

Waters Corporation (NYSE:WAT) reached a significant regulatory milestone on April 8, 2026, with the U.S. Food and Drug Administration granting clearance for the Onclarity HPV Self-Collection Kit and approval for the associated assay for at-home use.

Odyssey Marine Exploration (NASDAQ:OMEX) and American Ocean Minerals announced on April 8, 2026, that they have entered into a definitive merger agreement to combine their businesses, creating a premier platform for deep-sea critical minerals research and resource extraction.

Barrick Gold (NYSE:B) welcomed a decisive legal victory on April 8, 2026, as the Ontario Court of Appeal dismissed an appeal brought by a group of Tanzanian residents concerning alleged human rights incidents near the North Mara gold mine.

iBio (NASDAQ:IBIO), an AI-driven pioneer in antibody discovery and development, announced on April 8, 2026, that it has received the necessary regulatory clearances to begin its Phase 1 clinical trial of IBIO-600, a novel candidate for the treatment of obesity.

Plus Therapeutics (NASDAQ:PSTV), a clinical-stage pharmaceutical company developing targeted radiotherapeutics for central nervous system (CNS) cancers, announced on April 8, 2026, that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to REYOBIQ™ (rhenium Re186 obisbemeda).

Osisko Gold Royalties(NYSE:OR) reported record-breaking preliminary financial results for the first quarter of 2026 on April 8, bolstered by strong production across its core royalty portfolio and high precious metal prices.

Bausch + Lomb (NYSE:BLCO), a leader in eye health, announced on April 8, 2026, that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Bi-Blade+ dual-port vitrectomy cutter and an advanced Adaptive Fluidics update for the Stellaris Elite® Vision Enhancement System.

United Therapeutics (NASDAQ:UTHR), a leader in regenerative medicine and organ manufacturing, announced on April 8, 2026, that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its investigational miroliverELAP®.

RPM International (NYSE:RPM) reported record financial results for its fiscal 2026 third quarter ended February 28, 2026, characterized by robust top-line growth and a significant expansion in operating margins across its global specialty coatings and building materials portfolio.

The Mosaic Company (NYSE:MOS) announced a significant restructuring of its Brazilian operations on April 8, 2026, confirming plans to idle and demobilize its Araxá Mining and Chemical Complex and halt related mining at Patrocínio.

Cango (NYSE:CANG), a global Bitcoin miner and energy infrastructure developer, announced its March 2026 operational update on April 8, detailing a strategic pivot toward a lean-production model that prioritizes cash margins over aggressive scale.

Nurix Therapeutics (NASDAQ:NRIX), a clinical-stage biopharmaceutical company focused on small molecule therapies for cancer and immune disorders, reported its first-quarter 2026 financial results and provided a comprehensive update on its lead clinical programs on April 8, 2026.

AtaiBeckley (NASDAQ:ATAI), a clinical-stage biopharmaceutical company developing next-generation mental health treatments, reported on April 8, 2026, peer-reviewed Phase 2a results demonstrating that a single intranasal dose of BPL-003 achieved rapid and sustained clinical benefits in patients with Treatment-Resistant Depression (TRD).

Pony.ai (NASDAQ:PONY), a global leader in autonomous driving technology, reached a historic milestone on April 8, 2026, with the launch of Europe’s first commercial robotaxi service in Zagreb, Croatia.

ECARX Holdings (NASDAQ:ECX), a global leader in automotive intelligence technology, announced on April 8, 2026, that its Board of Directors has approved a preliminary plan to pursue the acquisition of a minority interest and specific intellectual property assets related to FlyMe OS.

Accenture (NYSE:ACN) has acquired Keepler Data Tech, a prominent Spanish cloud-native AI and data firm, in a strategic move to accelerate its ability to reinvent core business processes for global clients through advanced intelligence solutions.

United Microelectronics (NYSE:UMC), a leading global semiconductor foundry, reported on April 8, 2026, its unaudited net sales for March 2026, showing continued year-over-year gains in a stabilizing global chip market.

Mesoblast (NASDAQ:MESO) announced on April 7, 2026, that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to proceed directly to a registrational trial for Ryoncil® (remestemcel-L) in children with Duchenne muscular dystrophy (DMD).

Shell (NYSE:SHEL) updated its first-quarter 2026 outlook on April 8, raising its indicative refining margin to $17 per barrel while warning that the ongoing conflict in the Middle East is driving increased uncertainty across its global operations.